Demystifying the Treatment Options for Blood Clots – April Online Support Group
Dr. Alec Schmaier discusses the different treatment options available for patients with blood clots during the April 2018 Online Blood…
April 18, 2018
There are many different treatments available for blood clots. Some patients are put on medications, such as warfarin or DOACs. Other patients receive mechanical interventions, such as filters.
Arm yourself with the knowledge you need be be informed about your healthcare decisions.
February 26, 2018
The Importance of Follow-Up Care – Feb. Online Support Group
Dr. Rachel Rosovsky discusses the importance of receiving follow-up care after a blood clot. And, in an NATF first, a…
February 26, 2018
A DOAC Deep Dive: Rivaroxaban
For the past several decades, warfarin has been the go-to anticoagulant for doctors, but new treatments have recently emerged in…
February 26, 2018
COMPASS: A New Direction for Patients with Heart Disease?
By Aaron P Kithcart, MD PhD This past fall, at the annual meeting of the American Heart Association, the results…
January 5, 2018
A DOAC Deep Dive: Apixaban
For the past several decades, warfarin has been the go-to anticoagulant drug for doctors, but new treatments have emerged in…
January 3, 2018
Anticoagulant Comparison Chart 2018
After being diagnosed with a blood clot, navigating the different medications can be confusing. NATF has designed a chart comparing…
November 26, 2017
Preventing Bleeding While on Anticoagulants
Dr. Elaine Hylek discusses the prevention of bleeding on anticoagulants. Originally filmed Nov. 2017 for NATF’s online support group.
October 16, 2017
INR In-Home Testing: Accessible and Convenient
Patients on warfarin need to get their INR levels measured regularly. This often involves visiting a local anticoagulation clinic or…
September 26, 2017
PERT: The Role of a Pulmonary Embolism Response Team
Dr. Brett Carroll discusses PERT and how it is helping PE patients during NATF’s September 2017 online support group.
September 12, 2017
PERT: A New Model of Care
When Mark went to the hospital, he had never heard of a pulmonary embolism (PE). But at 49 years old,…
August 26, 2017
The EINSTEIN Choice Trial
Dr. Jeffrey Weitz discusses the implications of the EINSTEIN Choice Trial during NATF’s August 2017 online support group.
August 7, 2017
A DOAC Deep Dive: Dabigatran
For the past several decades, warfarin has been the go-to anticoagulant drug for doctors, but now new treatments have emerged…